[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Fluphenazine.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Fluphenazine.]
[N05AL01, sulpiride, Fluphenazine may increase the antipsychotic activities of Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sulthiame.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Fluphenazine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Fluphenazine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Fluphenazine.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Fluphenazine.]
[N07XX06, tetrabenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N04BC07, apomorphine, The therapeutic efficacy of Apomorphine can be decreased when used in combination with Fluphenazine.]
[L04AX02, thalidomide, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Fluphenazine.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Fluphenazine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Fluphenazine.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Fluphenazine.]
[N02AX01, tilidine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Fluphenazine.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Fluphenazine.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Fluphenazine.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tolperisone.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Fluphenazine.]
[N06AF04, tranylcypromine, The risk or severity of extrapyramidal symptoms can be increased when Tranylcypromine is combined with Fluphenazine.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trazodone.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triazolam.]
[A03AB12, mepenzolate, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trifluperidol.]
[N05AA05, triflupromazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Fluphenazine.]
[A03AA05, trimebutine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Fluphenazine.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Fluphenazine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Fluphenazine.]
[A03BB01, butylscopolamine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of adverse effects can be increased when Vilazodone is combined with Fluphenazine.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Fluphenazine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tubocurarine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ezogabine.]
[N06AX09, viloxazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Viloxazine.]
[L01CA02, vincristine, Vincristine may increase the neurotoxic activities of Fluphenazine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levetiracetam.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ziprasidone.]
[G04BD07, tolterodine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, The serum concentration of Atenolol can be increased when it is combined with Fluphenazine.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Atracurium.]
[S01FA01, atropine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fluphenazine.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Fluphenazine.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AC02, calcium silicate, Calcium silicate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Barbital.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N04BD02, rasagiline, The therapeutic efficacy of Rasagiline can be decreased when used in combination with Fluphenazine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluphenazine.]
[R06AC06, thonzylamine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fluphenazine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Fluphenazine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Fluphenazine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pomalidomide.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benperidol.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Fluphenazine.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Fluphenazine.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Fluphenazine.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Naratriptan is combined with Fluphenazine.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzatropine.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Fluphenazine.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Fluphenazine.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Vortioxetine is combined with Fluphenazine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Eslicarbazepine.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Fluphenazine.]
[C07AB04, acebutolol, The serum concentration of Acebutolol can be increased when it is combined with Fluphenazine.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tasimelteon.]
[S01ED02, betaxolol, The serum concentration of Betaxolol can be increased when it is combined with Fluphenazine.]
[A03BA03, hyoscyamine, Fluphenazine may increase the anticholinergic activities of Hyoscyamine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alfaxalone.]
[D11AA01, glycopyrronium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Fluphenazine.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Acepromazine.]
[A06AH03, naloxegol, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Naloxegol.]
[N04AA02, biperiden, The therapeutic efficacy of Biperiden can be decreased when used in combination with Fluphenazine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Fluphenazine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fluphenazine.]
[N06AX11, mirtazapine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[N02BE01, acetaminophen, Fluphenazine may increase the hepatotoxic activities of Acetaminophen.]
[A03AA09, difemerine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Fluphenazine.]
[A07DA06, eluxadoline, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brexpiprazole.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flibanserin.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Acetazolamide.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Fluphenazine.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Acetophenazine.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Fluphenazine.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Fluphenazine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Aprobarbital.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brivaracetam.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bromazepam.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Fluphenazine.]
[A02AD05, aluminum magnesium silicate, Almasilate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fluphenazine.]
[N06AA19, amineptin, The serum concentration of Amineptine can be increased when it is combined with Fluphenazine.]
[N05AX17, pimavanserin, Fluphenazine may increase the neurotoxic activities of Pimavanserin.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Aniracetam.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fluphenazine.]
[C07AA19, bupranolol, The serum concentration of Bupranolol can be increased when it is combined with Fluphenazine.]
[N07BC01, buprenorphine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Fluphenazine.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Artemether is combined with Fluphenazine.]
[P01BE03, artesunate, The risk or severity of QTc prolongation can be increased when Artesunate is combined with Fluphenazine.]
[N02AF01, butorphanol, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Butorphanol.]
[S01GX07, azelastine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Fluphenazine.]
[N07XX16, deutetrabenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Fluphenazine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Beclamide.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxybuprocaine.]
[A12AA04, calcium carbonate, Calcium carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XX08, linezolid, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Fluphenazine.]
[J05AE09, tipranavir, The metabolism of Tipranavir can be decreased when combined with Fluphenazine.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Fluphenazine.]
[N04BD03, safinamide, The therapeutic efficacy of Safinamide can be decreased when used in combination with Fluphenazine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Fluphenazine.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Fluphenazine.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Efavirenz.]
[C07AA17, bopindolol, The serum concentration of Bopindolol can be increased when it is combined with Fluphenazine.]
[N04AA11, bornaprine, The therapeutic efficacy of Bornaprine can be decreased when used in combination with Fluphenazine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brotizolam.]
[N04BX03, budipine, The therapeutic efficacy of Budipine can be decreased when used in combination with Fluphenazine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Fluphenazine.]
[N06AA15, butriptyline, The serum concentration of Butriptyline can be increased when it is combined with Fluphenazine.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vinylbital.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fluphenazine.]
[A03AA03, camylofine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The serum concentration of Carvedilol can be increased when it is combined with Fluphenazine.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluphenazine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Fluphenazine.]
[C07AB08, celiprolol, The serum concentration of Celiprolol can be increased when it is combined with Fluphenazine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fluphenazine.]
[P01BA07, tafenoquine, The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Fluphenazine.]
[N03AX17, stiripentol, The metabolism of Fluphenazine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Fluphenazine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Fluphenazine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Carbromal.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Fluphenazine.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fluphenazine.]
[R03BB08, revefenacin, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Fluphenazine is combined with Amifampridine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fluphenazine.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Fluphenazine.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Esketamine.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brexanolone.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Clobazam is combined with Fluphenazine.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cloxazolam.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyamemazine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Fluphenazine.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be decreased when combined with Fluphenazine.]
[N04CX01, istradefylline, The therapeutic efficacy of Istradefylline can be decreased when used in combination with Fluphenazine.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Fluphenazine.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fluphenazine.]
[N03AX25, cenobamate, The therapeutic efficacy of Cenobamate can be decreased when used in combination with Fluphenazine.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fluphenazine.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Fluphenazine.]
[N02AX03, dezocine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Lumateperone is combined with Fluphenazine.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Fluphenazine.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fluphenazine.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dichloralphenazone.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Fluphenazine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Fluphenazine.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fluphenazine.]
[A03AA08, dihexyverine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[N04BX04, opicapone, The therapeutic efficacy of Opicapone can be decreased when used in combination with Fluphenazine.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Fluphenazine.]
[P01BE01, artemisinin, The risk or severity of QTc prolongation can be increased when Artemisinin is combined with Fluphenazine.]
[G04BD09, trospium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dyclonine.]
[P01BB01, proguanil, The risk or severity of QTc prolongation can be increased when Proguanil is combined with Fluphenazine.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Remimazolam.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fluphenazine is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Fluphenazine.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Fluphenazine.]
[N05AA01, chlorpromazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Fluphenazine.]
[N05AF03, chlorprothixene, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fluphenazine.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Etifoxine.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethyl loflazepate.]
[L01FX21, naxitamab, Fluphenazine may increase the neurotoxic activities of Naxitamab.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Felbamate.]
[C01CA19, fenoldopam, The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Fluphenazine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Fluphenazine.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Fluphenazine.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trichloroethylene.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Fluphenazine.]
[N06AB04, citalopram, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Citalopram.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Fluphenazine.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Fluphenazine.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Fluphenazine.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Fluphenazine.]
[J01FF01, clindamycin, Fluphenazine may increase the neurotoxic activities of Clindamycin.]
[N06AX25, St. John's wort extract, The risk or severity of adverse effects can be increased when Fluphenazine is combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Fluphenazine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levobupivacaine.]
[N06AA04, clomipramine, The serum concentration of desmethylclomipramine, an active metabolite of Clomipramine, can be increased when used in combination with Fluphenazine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonidine.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Granisetron.]
[N05AH02, clozapine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Halazepam.]
[S02DA02, cocaine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Fluphenazine.]
[R05DA04, codeine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Codeine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Hexafluronium.]
[A03AB10, hexocyclium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tropisetron.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Fluphenazine.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Fluphenazine.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Fluphenazine.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Fluphenazine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desloratadine.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Almotriptan is combined with Fluphenazine.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketazolam.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Fluphenazine.]
[N03AX09, lamotrigine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[N07BC04, lofexidine, The therapeutic efficacy of Fluphenazine can be increased when used in combination with Lofexidine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lormetazepam.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A03AA04, mebeverine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Medifoxamine.]
[C07AA14, mepindolol, The serum concentration of Mepindolol can be increased when it is combined with Fluphenazine.]
[R06AD07, mequitazine, Fluphenazine may increase the arrhythmogenic activities of Mequitazine.]
[N04AA03, methixene, The therapeutic efficacy of Metixene can be decreased when used in combination with Fluphenazine.]
[R03CB02, methoxyphenamine, Fluphenazine may decrease the stimulatory activities of Methoxyphenamine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyclobarbital.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Melperone.]
[L01AA01, cyclophosphamide, Cyclophosphamide may increase the neurotoxic activities of Fluphenazine.]
[N06AX07, minaprine, The risk or severity of extrapyramidal symptoms can be increased when Minaprine is combined with Fluphenazine.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Fluphenazine.]
[S01XA18, cyclosporine, Cyclosporine may increase the neurotoxic activities of Fluphenazine.]
[N06AG02, moclobemide, The risk or severity of extrapyramidal symptoms can be increased when Moclobemide is combined with Fluphenazine.]
[R06AX02, cyproheptadine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of QTc prolongation can be increased when Dapsone is combined with Fluphenazine.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Fluphenazine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nordazepam.]
[C07AB12, nebivolol, The serum concentration of Nebivolol can be increased when it is combined with Fluphenazine.]
[N06AX06, nefazodone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Niaprazine.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tiagabine.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Fluphenazine.]
[R05DA06, normethadone, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Escitalopram.]
[G04BD08, solifenacin, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[N06AA01, desipramine, The serum concentration of Desipramine can be increased when it is combined with Fluphenazine.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxcarbazepine.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxiracetam.]
[N04AA08, dexetimide, The therapeutic efficacy of Dexetimide can be decreased when used in combination with Fluphenazine.]
[G04BD04, oxybutynin, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Fluphenazine.]
[A03AA01, oxyphencyclimine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Fluphenazine.]
[N06BA02, dextroamphetamine, Fluphenazine may decrease the stimulatory activities of Amphetamine.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Fluphenazine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Paramethadione is combined with Fluphenazine.]
[N02AC01, dextromoramide, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Paroxetine.]
[N07BC06, heroin, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phensuximide.]
[N06AA08, dibenzepin, The serum concentration of Dibenzepin can be increased when it is combined with Fluphenazine.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Cinchocaine is combined with Fluphenazine.]
[A03AA07, dicyclomine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Fluphenazine may increase the neurotoxic activities of Didanosine.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pipamperone.]
[A03AB14, pipenzolate, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Fluphenazine.]
[A08AA03, diethylpropion, Fluphenazine may decrease the stimulatory activities of Diethylpropion.]
[A03AB11, poldine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluphenazine.]
[N02AA03, hydromorphone, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Hydromorphone.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Fluphenazine.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pridinol.]
[R06AB03, dimethindene, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Fluphenazine.]
[R06AA02, diphenhydramine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The serum concentration of Quinupramine can be increased when it is combined with Fluphenazine.]
[A03FA02, cisapride, The risk or severity of adverse effects can be increased when Cisapride is combined with Fluphenazine.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Fluphenazine.]
[C01BA03, disopyramide, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fluphenazine.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Fluphenazine.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be decreased when combined with Fluphenazine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fluphenazine.]
[N06AA16, dothiepin, The serum concentration of Dosulepin can be increased when it is combined with Fluphenazine.]
[N06AA12, doxepin, The serum concentration of Doxepin can be increased when it is combined with Fluphenazine.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Fluphenazine.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluphenazine.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Fluphenazine.]
[C07AA16, tertatolol, The serum concentration of Tertatolol can be increased when it is combined with Fluphenazine.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiopropazate.]
[G04BD01, emepronium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The serum concentration of Tianeptine can be increased when it is combined with Fluphenazine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of extrapyramidal symptoms can be increased when Toloxatone is combined with Fluphenazine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Fluphenazine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Fluphenazine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triclofos.]
[A03AB08, tridihexethyl, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, The therapeutic efficacy of Tropatepine can be decreased when used in combination with Fluphenazine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Fluphenazine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Fluphenazine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fluphenazine.]
[N05CF02, zolpidem, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Fluphenazine.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Moricizine.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Ergometrine is combined with Fluphenazine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluphenazine.]
[N02CA02, ergotamine, The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluphenazine.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Fluphenazine.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Estazolam.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Fluphenazine.]
[C01CA15, gepefrine, Fluphenazine may decrease the stimulatory activities of Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Fluphenazine.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluphenazine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Ethosuximide is combined with Fluphenazine.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethotoin.]
[S01XA06, ethylmorphine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Ethylmorphine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Fluphenazine.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Fluphenazine.]
[R06AX12, terfenadine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Fluphenazine.]
[N06AB08, fluvoxamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Fluphenazine.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Fluphenazine.]
[N02AB03, fentanyl, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Fentanyl.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Fluphenazine.]
[G04BD02, flavoxate, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Fluphenazine.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunitrazepam.]
[N06AA14, melitracen, The serum concentration of Melitracen can be increased when it is combined with Fluphenazine.]
[V03AZ01, ethanol, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[N06AB03, fluoxetine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Fluphenazine.]
[N07XX04, sodium oxybate, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flurazepam.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fluspirilene.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of extrapyramidal symptoms can be increased when Furazolidone is combined with Fluphenazine.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Fluphenazine is combined with Eszopiclone.]
[N05AL05, amisulpride, Fluphenazine may increase the antipsychotic activities of Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Fluphenazine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gallamine.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bifemelane.]
[N04BC06, cabergoline, The therapeutic efficacy of Cabergoline can be decreased when used in combination with Fluphenazine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Alfentanil.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Fluphenazine.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Fluphenazine.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Fluphenazine.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Glutethimide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Fluphenazine.]
[C07AB09, esmolol, The serum concentration of Esmolol can be increased when it is combined with Fluphenazine.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Fluphenazine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Fluphenazine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Halothane.]
[N05AH04, quetiapine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Fluphenazine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Allobarbital.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Fluphenazine.]
[R05DA03, hydrocodone, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[G04BD06, propiverine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Fluphenazine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[B05CB02, sodium citrate, Fluphenazine may increase the neurotoxic activities of Sodium citrate.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Fluphenazine.]
[N01AH03, sufentanil, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Sufentanil.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Fluphenazine.]
[L01CD01, paclitaxel, Fluphenazine may increase the neurotoxic activities of Paclitaxel.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tizanidine.]
[N06AX17, milnacipran, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Milnacipran.]
[A03AA30, piperidolate, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Fluphenazine.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ramelteon.]
[R06AE01, buclizine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C07AA01, alprenolol, The serum concentration of Alprenolol can be increased when it is combined with Fluphenazine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Fluphenazine.]
[J05AF04, stavudine, Fluphenazine may increase the neurotoxic activities of Stavudine.]
[N06AA13, iprindole, The serum concentration of Iprindole can be increased when it is combined with Fluphenazine.]
[N06AF05, iproniazid, The risk or severity of extrapyramidal symptoms can be increased when Iproniazid is combined with Fluphenazine.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of extrapyramidal symptoms can be increased when Isocarboxazid is combined with Fluphenazine.]
[P01AX06, atovaquone, The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Fluphenazine.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Isoflurane.]
[N04BX02, entacapone, The therapeutic efficacy of Entacapone can be decreased when used in combination with Fluphenazine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Fluphenazine.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketanserin.]
[N05AH03, olanzapine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[N04BC09, rotigotine, Fluphenazine may increase the sedative activities of Rotigotine.]
[C07AG01, labetalol, The serum concentration of Labetalol can be increased when it is combined with Fluphenazine.]
[N04BB01, amantadine, The therapeutic efficacy of Amantadine can be decreased when used in combination with Fluphenazine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lacosamide.]
[N04BA01, levodopa, The therapeutic efficacy of Levodopa can be decreased when used in combination with Fluphenazine.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Fluphenazine.]
[J01FF02, lincomycin, Fluphenazine may increase the neurotoxic activities of Lincomycin.]
[N02CA07, lisuride, The therapeutic efficacy of Lisuride can be decreased when used in combination with Fluphenazine.]
[N06AA07, lofepramine, The serum concentration of Lofepramine can be increased when it is combined with Fluphenazine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Fluphenazine.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Fluphenazine.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Fluphenazine can be increased when used in combination with Magnesium sulfate.]
[N06AA21, maprotiline, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Fluphenazine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Meclizine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Medazepam.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Fluphenazine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Melatonin.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluphenazine.]
[N02AB02, meperidine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Meperidine.]
[C01CA11, mephentermine, Fluphenazine may decrease the stimulatory activities of Mephentermine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Fluphenazine.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Fluphenazine.]
[N02AX05, meptazinol, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Fluphenazine.]
[N06BA03, methamphetamine, Fluphenazine may decrease the stimulatory activities of Metamfetamine.]
[A03AB07, methantheline, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Fluphenazine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Metergoline.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fluphenazine.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Fluphenazine.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Fluphenazine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methoxyflurane.]
[V04CG05, methylene blue, The risk or severity of extrapyramidal symptoms can be increased when Methylene blue is combined with Fluphenazine.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methylphenidate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Fluphenazine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Fluphenazine.]
[A03FA01, metoclopramide, The risk or severity of adverse effects can be increased when Metoclopramide is combined with Fluphenazine.]
[C07AB02, metoprolol, The serum concentration of Metoprolol can be increased when it is combined with Fluphenazine.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Fluphenazine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Mianserin is combined with Fluphenazine.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Fluphenazine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Midazolam.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N06BA12, lisdexamfetamine, Fluphenazine may decrease the stimulatory activities of Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Molindone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fluphenazine.]
[N02AA01, morphine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Morphine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Fluphenazine.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Fluphenazine.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amobarbital.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Fluphenazine.]
[N06AA17, amoxapine, The serum concentration of Amoxapine can be increased when it is combined with Fluphenazine.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be increased when it is combined with Fluphenazine.]
[C07AA12, nadolol, The serum concentration of Nadolol can be increased when it is combined with Fluphenazine.]
[N04BC04, ropinirole, The therapeutic efficacy of Ropinirole can be decreased when used in combination with Fluphenazine.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Naltrexone.]
[N06BA01, amphetamine, Fluphenazine may decrease the stimulatory activities of Amphetamine.]
[N06AX21, duloxetine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Duloxetine.]
[N04BX01, tolcapone, The therapeutic efficacy of Tolcapone can be decreased when used in combination with Fluphenazine.]
[S03AA01, neomycin, Fluphenazine may increase the neurotoxic activities of Neomycin.]
[N01AH06, remifentanil, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desvenlafaxine.]
[N06AF02, nialamide, The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with Fluphenazine.]
[C08CA04, nicardipine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Fluphenazine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Fluphenazine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nitrazepam.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zaleplon.]
[N04BC05, pramipexole, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Fluphenazine.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nomifensine.]
[N06AA05, opipramol, The serum concentration of Opipramol can be increased when it is combined with Fluphenazine.]
[N02AA02, opium, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Opium.]
[G02CB04, quinagolide, The therapeutic efficacy of Quinagolide can be decreased when used in combination with Fluphenazine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Fluphenazine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxazepam.]
[C07AA02, oxprenolol, The serum concentration of Oxprenolol can be increased when it is combined with Fluphenazine.]
[N02AA05, oxycodone, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxypertine.]
[A03AB03, oxyphenonium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[M03AC01, pancuronium, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[N05CC05, paraldehyde, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of extrapyramidal symptoms can be increased when Pargyline is combined with Fluphenazine.]
[G04BD11, fesoterodine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The serum concentration of Penbutolol can be increased when it is combined with Fluphenazine.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Fluphenazine.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Perazine.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be decreased when used in combination with Fluphenazine.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Fluphenazine.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Fluphenazine.]
[N02AD02, phenazocine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of extrapyramidal symptoms can be increased when Phenelzine is combined with Fluphenazine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Fluphenazine.]
[N03AA02, phenobarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Phenoperidine.]
[A08AA01, phentermine, Fluphenazine may decrease the stimulatory activities of Phentermine.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Fluphenazine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Fluphenazine.]
[C07AA03, pindolol, The serum concentration of Pindolol can be increased when it is combined with Fluphenazine.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Fluphenazine.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pipotiazine.]
[A02BX03, pirenzepine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N04BC08, piribedil, The therapeutic efficacy of Piribedil can be decreased when used in combination with Fluphenazine.]
[N02AC03, pirinitramide, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Piritramide.]
[N02CX01, pizotyline, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Delavirdine can be decreased when combined with Fluphenazine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Proxibarbal.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alosetron.]
[S03AA03, polymyxin B, Fluphenazine may increase the neurotoxic activities of Polymyxin B.]
[J05AE03, ritonavir, The metabolism of Ritonavir can be decreased when combined with Fluphenazine.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Fluphenazine.]
[C07AB01, practolol, The serum concentration of Practolol can be increased when it is combined with Fluphenazine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Prazepam.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Primaquine is combined with Fluphenazine.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Primidone.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Fluphenazine.]
[S01HA05, procaine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Fluphenazine.]
[L01XB01, procarbazine, The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Fluphenazine.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fluphenazine.]
[N04AA04, procyclidine, The therapeutic efficacy of Procyclidine can be decreased when used in combination with Fluphenazine.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Fluphenazine.]
[N05AA03, promazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[C01BC03, propafenone, The serum concentration of Propafenone can be increased when it is combined with Fluphenazine.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Propanidid.]
[A03AB05, propantheline, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Periciazine.]
[N05CM06, propiomazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Fluphenazine.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Rizatriptan is combined with Fluphenazine.]
[N06AA11, protriptyline, The serum concentration of Protriptyline can be increased when it is combined with Fluphenazine.]
[R01BA02, pseudoephedrine, Fluphenazine may decrease the stimulatory activities of Pseudoephedrine.]
[N05AX12, aripiprazole, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Fluphenazine is combined with Dalfampridine.]
[A03AB15, diphemanil, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Fluphenazine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mepyramine.]
[P01BD01, pyrimethamine, The risk or severity of QTc prolongation can be increased when Pyrimethamine is combined with Fluphenazine.]
[P01AX05, quinacrine, The risk or severity of QTc prolongation can be increased when Quinacrine is combined with Fluphenazine.]
[C01BA01, quinidine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Fluphenazine.]
[P01BC01, quinine, The risk or severity of QTc prolongation can be increased when Quinine is combined with Fluphenazine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Fluphenazine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxitriptan.]
[S01FA02, scopolamine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Fluphenazine.]
[N04BD01, selegiline, The therapeutic efficacy of Selegiline can be decreased when used in combination with Fluphenazine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Fluphenazine.]
[R03BB01, ipratropium bromide, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
